Skip To Main

How are these new GLP-1 medications different from older treatments for obesity?

New GLP-1 and GLP-1 combination medications like semaglutide (Wegovy®) and tirzepatide (Mounjaro™) show significantly higher and more durable weight loss results compared to earlier medications. They also improve broader metabolic health markers, reducing the risk of chronic conditions that drive long-term healthcare costs.

Cookie Usage

Our Website uses cookies to provide you with the best experience. Please select your preferences below. Learn more in our Privacy Policy.

  • NecessaryAlways active

    Required for the site to function, including storing your cookie preferences.

  • Marketing & Analytics

    Help us understand how you use our site and measure marketing performance. Includes Google Tag Manager, HubSpot, Microsoft Clarity, VWO, and Digioh.

  • Advertising

    Used by our advertising and affiliate partners, including Commission Junction.